Luvox

See also: Generic Luvox CR

Luvox is a brand name of fluvoxamine, approved by the FDA in the following formulation(s):

LUVOX (fluvoxamine maleate - tablet; oral)

• 
  Manufacturer: ANI PHARMS
  
  Approval date: December 20, 2007
  
  Strength(s): 100MG ^[AB], 25MG ^[AB], 50MG ^[AB]

Has a generic version of Luvox been approved?

A generic version of Luvox has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Luvox and have been approved by the FDA:

fluvoxamine maleate tablet; oral

• 
  Manufacturer: APOTEX
  
  Approval date: May 7, 2001
  
  Strength(s): 100MG ^[AB], 25MG ^[AB], 50MG ^[AB]


• 
  Manufacturer: BARR
  
  Approval date: January 25, 2001
  
  Strength(s): 100MG ^[AB], 25MG ^[AB], 50MG ^[AB]


• 
  Manufacturer: CARACO
  
  Approval date: February 23, 2006
  
  Strength(s): 100MG ^[AB], 25MG ^[AB], 50MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: November 29, 2000
  
  Strength(s): 100MG ^[AB], 25MG ^[AB], 50MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: November 29, 2000
  
  Strength(s): 25MG ^[AB], 50MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: September 10, 2002
  
  Strength(s): 100MG ^[AB], 25MG ^[AB], 50MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Luvox. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Luvox.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • April 14, 2011 - ADDITIONAL INFORMATION ADDED TO LABELING REGARDING ESTABLISHMENT OF EFFICACY IN ADDITIONAL CLINICAL TRIALS AND ONE MAINTENANCE TRIAL
  
  

See also...

• Luvox Consumer Information (Cerner Multum)
• Luvox Advanced Consumer Information (Micromedex)
• Fluvoxamine Consumer Information (Wolters Kluwer)
• Fluvoxamine Extended-Release Capsules Consumer Information (Wolters Kluwer)
• Fluvoxamine Consumer Information (Cerner Multum)
• Fluvoxamine Advanced Consumer Information (Micromedex)
• Fluvoxamine Maleate AHFS DI Monographs (ASHP)